MedPath
NMPA Approval

Dapoxetine Hydrochloride Tablets

H20150564

April 1, 2020

H20150564

Drug Information

盐酸达泊西汀片

必利劲

片剂

60mg

化学药品

April 1, 2020

March 31, 2025

Company Information

Applicant Company

BERLIN-CHEMIE AG

Glienicker Weg 125 12489 Berlin Federal Republic of Germany

Manufacturing Company

Leipziger Straβe 7-13 01097 Dresden Federal Republic of Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸达泊西汀片 - NMPA 批准文号 | MedPath